XML 39 R28.htm IDEA: XBRL DOCUMENT v3.25.1
Equity
 3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Equity Equity
The following tables provides a summary of changes to accumulated other comprehensive income (loss) by component for three months ended March 31, 2025 and 2024.
Table 20.1 – Changes in Accumulated Other Comprehensive Income (Loss) by Component
Three Months Ended March 31, 2025Three Months Ended March 31, 2024
(In Thousands)AFS SecuritiesInterest Rate Agreements Accounted for as Cash Flow HedgesTotalAFS SecuritiesInterest Rate Agreements Accounted for as Cash Flow HedgesTotal
Balance at beginning of period$20,967 $(64,038)$(43,071)$10,219 $(68,176)$(57,957)
Other comprehensive income
before reclassifications 		3,422 — 3,422 8,656 — 8,656 
Amounts reclassified from other
accumulated comprehensive income (loss)		(709)1,018 309 (629)1,029 400 
Net current-period other comprehensive income (loss)2,713 1,018 3,731 8,027 1,029 9,056 
Balance at End of Period$23,680 $(63,020)$(39,340)$18,246 $(67,147)$(48,901)
The following tables provide a summary of reclassifications out of Accumulated other comprehensive income (loss) for the three months ended March 31, 2025 and 2024.
Table 20.2 – Reclassifications Out of Accumulated Other Comprehensive Income (Loss)
Amount Reclassified From
Accumulated Other Comprehensive Loss
Affected Line Item in theThree Months Ended March 31,
(In Thousands)Income Statement20252024
Net Realized (Gain) Loss on AFS Securities
Decrease in allowance for credit losses on AFS securitiesInvestment fair value changes, net$(67)$(629)
(Gain) loss on sale of AFS securitiesRealized gains, net(642)— 
$(709)$(629)
Net Realized Loss on Interest Rate Agreements Designated as Cash Flow Hedges
Amortization of deferred lossInterest expense$1,018 $1,029 
$1,018 $1,029 
We have an established program to sell common stock from time to time in at-the-market ("ATM") offerings. During the three months ended March 31, 2025, we did not issue any shares of common stock under this program. At March 31, 2025, the remaining share issuance capacity under this program was approximately $50 million.
Issuance of Preferred Stock
In January 2023, Redwood issued 2.8 million shares of 10.00% Series A Fixed-Rate Reset Cumulative Redeemable Preferred Stock ("Series A Preferred Stock") for gross proceeds of $70 million and net proceeds of approximately $67 million, after deducting the underwriting discount and other estimated expenses. The Series A Preferred Stock pays quarterly cumulative cash dividends through January 15, 2028 at a fixed annual rate of 10%, based on the stated liquidation preference of $25.00 per share, in arrears, when authorized by Redwood's Board of Directors and declared by the Company. Starting April 15, 2028, the annual dividend rate will reset to the five-year U.S. Treasury Rate plus a spread of 6.278%. The Series A Preferred Stock ranks senior to Redwood's common stock with respect to rights to the payment of dividends and the distribution of assets upon any liquidation, dissolution or winding up of the Company. During the three months ended March 31, 2025, the Company declared preferred stock dividends of $0.625 per preferred share. At March 31, 2025, preferred dividends payable totaling $1 million for the first quarter 2025 dividend were included in Accrued expenses and other liabilities and were payable on April 15, 2025 to preferred stockholders of record on April 1, 2025.
Direct Stock Purchase and Dividend Reinvestment Plan
During the three months ended March 31, 2025, we did not issue any shares of common stock through our Direct Stock Purchase and Dividend Reinvestment Plan. At March 31, 2025, approximately six million shares remained outstanding for future offerings under this plan.
Common Stock Warrants
In conjunction with establishing the joint venture with an institutional investment manager in March 2024, we issued warrants exercisable for 1,974,905 shares of our common stock (the “First Tranche Warrants”); and (ii) warrants exercisable for 4,608,112 shares of our common stock (the “Second Tranche Warrants” and together with the First Tranche Warrants, the “Warrants”). The First Tranche Warrants are exercisable from March 18, 2025 to March 18, 2029. The Second Tranche Warrants will vest upon achievement of specified deployment thresholds related to our joint venture with an institutional investment manager and, if vested, will be exercisable from the date the Second Tranche Warrants vest to March 18, 2029. The initial strike price of the Warrants is $7.76. The Warrants also contain a mandatory exercise provision, exercisable at Redwood’s option upon satisfaction of specified conditions, including the trading price of Redwood’s common stock exceeding a specified premium to the exercise price. Exercises of any Warrants will be settled on a net basis.
The Warrants met the criteria for equity classification under GAAP and are recorded as a component of Additional paid-in-capital in Equity on our Consolidated Balance Sheets. The Warrants were valued at $0.8 million on the issuance date and are not subject to subsequent remeasurement. See Note 21 for discussion on the impact of the Warrants on earnings per common share.
For additional information related to our equity, see Note 19 to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2024.